Company Overview and News

 
Cobalt Industry Overview And Analysis Of A Promising Junior Minor Poised For Growth

2018-02-27 seekingalpha
A global supply shortage of cobalt is imminent given the exploding demand for lithium ion batteries used in electric vehicles and other devices.
Upvote Downvote

 
BRIEF-Deutsche Rohstoff says Hammer Metals to establish JV with Global Energy Metals Corp.

2017-05-02 reuters
* Hammer Metals signs term sheet to establish a joint venture with Global Energy Metals Corp. Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Upvote Downvote

 
Hammer Metals among ASX % Gainers intra-day

2016-12-28 proactiveinvestors.com.au
Upvote Downvote

 
Hammer Metals assays silver, lead and cobalt at Millennium

2016-10-14 proactiveinvestors.com.au
Millennium is located close to the regional-scale Pilgrim Fault Zone which also hosts Hammer’s Kalman Copper-Gold-Molybdenum-Rhenium Deposit, 50 kilometres to the south. Hammer drilled a total of 23 new reverse circulation holes at Millennium and extended two previous holes. Highlights include: -  6 metres at 39 g/t silver and 1.63% lead from 50 metres; and - 8 metres at 0.35% cobalt and 0.08% copper from 128 metres (2.
Upvote Downvote

 
Hammer Metals Ltd heads to market to explore Mount Isa province

2016-07-29 proactiveinvestors.com.au
Hammer Metals Ltd (ASX:HMX) is focused on exploring its major land position covering circa 2600 square kilometres in the Mount Isa province of Australia. The region hosts majors such as Glencore and South32. Hammer is now heading to market with a capital raising, and the ASX has granted the company a trading halt to prepare. The halt will remain in place until the opening of trade on Tuesday 2nd August 2016, or earlier if an announcement is made to the market.
Upvote Downvote

 
Hammer Metals Ltd in call for cash

2016-04-05 proactiveinvestors.com.au
Hammer Metals Ltd (ASX:HMX) has been granted a trading halt by the ASX, pending details of a capital raising. The halt will remain in place until the opening of trade on Thursday 7th April 2016, or earlier if an announcement is made to the market.
Upvote Downvote

 
trading Halt

2016-04-05 asx.com.au
Upvote Downvote

 
Appendix 3B

2016-03-18 asx.com.au
Upvote Downvote

 

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...